Seok-Yeon Kim

A Phase III, Multicenter, Randomized, Double-blind, Active Comparator Clinical Trial to Compare the Efficacy and Safety of Combination Therapy With Ezetimibe and Rosuvastatin Versus Rosuvastatin Monotherapy in Patients With Hypercholesterolemia: I-ROSETTE (Ildong Rosuvastatin & Ezetimibe for Hypercholesterolemia) Randomized Controlled Trial

Soon Jun Hong, Han Saem Jeong, Jeong Cheon Ahn et al. · Clinical Therapeutics · 2018 · 63 citations · Full text

Pharmacy, Cardiology, Pharmacotherapy +15

Combination Therapy of Rosuvastatin and Ezetimibe in Patients with High Cardiovascular Risk

Young-June Yang, Sang‐Hak Lee, Sang‐Hak Lee et al. · Clinical Therapeutics · 2016 · 50 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +12

Effects of genetic variants on platelet reactivity and one-year clinical outcomes after percutaneous coronary intervention: A prospective multicentre registry study

Hyung Joon Joo, Sung Gyun Ahn, Jae Hyoung Park et al. · Scientific Reports · 2018 · 34 citations · Full text

Medicine, Cardiology, Pharmacology +17

A Randomized, Multicenter, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and the Tolerability of a Triple Combination of Amlodipine/Losartan/Rosuvastatin in Patients With Comorbid Essential Hypertension and Hyperlipidemia

Hae‐Young Lee, Seok-Yeon Kim, Kee‐Joon Choi et al. · Clinical Therapeutics · 2017 · 22 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Harmonizing Optimal Strategy for Treatment of coronary artery diseases – comparison of REDUCtion of prasugrEl dose or POLYmer TECHnology in ACS patients (HOST-REDUCE-POLYTECH-ACS RCT): study protocol for a randomized controlled trial

Joo Myung Lee, Ji-Hyun Jung, Kyung Woo Park et al. · Trials · 2015 · 14 citations · Full text

Medicine, Cardiology, Pharmacotherapy +17